Intelligence / Healthtech / FDA 510(k) Clearances / GenMark Diagnostics, Inc.
Approvalsdevice cleared30 Oct 2026
GenMark Diagnostics, Inc.
30 Oct 2026: Device cleared · cobas eplex respiratory pathogen panel 3. Recorded in the openFDA device 510(k) data.
- Decided
- 30 Oct 2026
- Device
- cobas eplex respiratory pathogen panel 3
- Specialty
- Microbiology
- Country
- United States
- Location
- Carlsbad, CA
- Clearance type
- Traditional
- 510(k) number
- K262938
- Submitted
- 2026-08-21
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at GenMark Diagnostics, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Microbiology
FDA 510(k) Clearances
6 NovBiofire Diagnostics, LLCdevice cleared · BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel; BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel MidApprovals4 NovBioFire Defense, LLCdevice cleared · BioFire Warrior Panel Control KitApprovals4 NovBIOMERIEUX, Inc.device cleared · VITEK 2 AST-Gram Negative Polymyxin B (<= 0.25 >=16µg/mL);VITEK 2 AST-Gram Negative Imipenem (<= 0.25 >=16µg/mL);VITEK 2 AST-Gram Negative Ceftazidime Avibactam (<= 0.125 >=16µg/mL)Approvals4 NovMolecular Designsdevice cleared · SimplicityDx Panel FluA/FluB/RSVApprovals3 NovbioMérieux, Inc.device cleared · VITEK PROApprovals30 OctMaine Molecular Quality Controls, Inc.device cleared · eplex RP3 Control M530; eplex RP3 NegativeApprovals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.